-
1
-
-
43449091883
-
Treatment of Refractory Status Epilepticus: Literature Review and a Proposed Protocol
-
DOI 10.1016/j.pediatrneurol.2008.01.001, PII S0887899408000349
-
Abend NS, Dlugos DJ (2008) Treatment of refractory status epilepticus: literature review and proposed protocol. Pediatr Neurol 38:377-390 (Pubitemid 351671983)
-
(2008)
Pediatric Neurology
, vol.38
, Issue.6
, pp. 377-390
-
-
Abend, N.S.1
Dlugos, D.J.2
-
2
-
-
0346787771
-
Topiramate and status epilepticus: Report of three cases
-
DOI 10.1016/j.yebeh.2003.07.016
-
Bensalem MK, Fakhoury TA (2003) Topiramate and status epilepticus: report ofthree cases. Epilepsy Behav 4:757-760 (Pubitemid 38035702)
-
(2003)
Epilepsy and Behavior
, vol.4
, Issue.6
, pp. 757-760
-
-
Bensalem, M.K.1
Fakhoury, T.A.2
-
3
-
-
0036126825
-
Refractory status epilepticius 2001
-
Bleck TP (2002) Refractory status epilepticius 2001. Arch Neurol 59:188-189
-
(2002)
Arch Neurol
, vol.59
, pp. 188-189
-
-
Bleck, T.P.1
-
4
-
-
17644402453
-
Pediatric refractory partial status epilepticus responsive to topiramate
-
Blumkin L, Lerman-Sagie T, Houri T, Gilad E, Nissenkorn A, Ginsberg M, Watemberg M (2005) Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol 20:239-241 (Pubitemid 40561772)
-
(2005)
Journal of Child Neurology
, vol.20
, Issue.3
, pp. 239-241
-
-
Blumkin, L.1
Lerman-Sagie, T.2
Houri, T.3
Gilad, E.4
Nissenkorn, A.5
Ginsberg, M.6
Watemberg, N.7
-
5
-
-
0037816146
-
Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients
-
DOI 10.1046/j.1528-1157.2003.64402.x
-
Doose DR, Brodie MJ, Wilson EA et al (2003) Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients. Epilepsia 44:917-922 (Pubitemid 36842181)
-
(2003)
Epilepsia
, vol.44
, Issue.7
, pp. 917-922
-
-
Doose, D.R.1
Brodie, M.J.2
Wilson, E.A.3
Chadwick, D.4
Oxbury, J.5
Berry, D.J.6
Schwabe, S.7
Bialer, M.8
-
6
-
-
0029804193
-
Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug
-
Doose DR, Walker SA, Gisclon LG, Nayak RK (1996) Single-dose pharmokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 36:884-891 (Pubitemid 26384477)
-
(1996)
Journal of Clinical Pharmacology
, vol.36
, Issue.10
, pp. 884-891
-
-
Doose, D.R.1
Walker, S.A.2
Gisclon, L.G.3
Nayak, R.K.4
-
7
-
-
0000844483
-
Evaluation of phenobarbital and primidone/phenobarbital plasma concentrations during administration of add-on topiramate theraphy in five multicenter, double-blind, placebo-controlled in ourpatients with partial seizures
-
Doose DR, Walker SA, Pledger G (1995) Evaluation of phenobarbital and primidone/phenobarbital plasma concentrations during administration of add-on topiramate theraphy in five multicenter, double-blind, placebo-controlled in ourpatients with partial seizures. Epilepsia 36(suppl 3):158
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 3
, pp. 158
-
-
Doose, D.R.1
Walker, S.A.2
Pledger, G.3
-
8
-
-
0029922566
-
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
-
Faught E, Wilder BJ, Ramsay RE, ReifeRA KLD, Pledger GW, Karim RM (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400- and, 600-mg daily dosages. Topiramate YD Study Group Neurology 46:1684-1690 (Pubitemid 26185793)
-
(1996)
Neurology
, vol.46
, Issue.6
, pp. 1684-1690
-
-
Faught, E.1
Wilder, B.J.2
Ramsay, R.E.3
Reife, R.A.4
Kramer, L.D.5
Pledger, G.W.6
Karim, R.M.7
-
9
-
-
58149154641
-
Levatiracetam in children with refractory status epilepticus
-
Gallentine WB, Hunnicut AS, Husain AM (2009) Levatiracetam in children with refractory status epilepticus. Epilepsy Behav 14:215-218
-
(2009)
Epilepsy Behav
, vol.14
, pp. 215-218
-
-
Gallentine, W.B.1
Hunnicut, A.S.2
Husain, A.M.3
-
10
-
-
67349108919
-
Topiramate
-
In: Pellock JM, Bourgeois BF, Dodson WE (eds Demos Medical Publishing, New York
-
Glauser TA (2008) Topiramate. In: Pellock JM, Bourgeois BF, Dodson WE (eds) Pediatric epilepsy diagnosis and therapy, 3rd edn. Demos Medical Publishing, New York, pp 671-683
-
(2008)
Pediatric Epilepsy Diagnosis and Therapy, 3rd Edn
, pp. 671-683
-
-
Glauser, T.A.1
-
11
-
-
33947175991
-
The anaesthetic and intensive care of status epilepticus
-
DOI 10.1097/WCO.0b013e328042bacb, PII 0001905220070400000012
-
Holtkamp M (2007) The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 20:188-193 (Pubitemid 46411505)
-
(2007)
Current Opinion in Neurology
, vol.20
, Issue.2
, pp. 188-193
-
-
Holtkamp, M.1
-
12
-
-
0142072683
-
Efficacy of Topiramate in Children with Refractory Status Epilepticus
-
DOI 10.1046/j.1528-1157.2003.11803.x
-
Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A (2003) Efficiacy oftopiramate in children with refractory status epilepticus. Epilepsia 44:1353-1356 (Pubitemid 37280381)
-
(2003)
Epilepsia
, vol.44
, Issue.10
, pp. 1353-1356
-
-
Kahriman, M.1
Minecan, D.2
Kutluay, E.3
Selwa, L.4
Beydoun, A.5
-
13
-
-
24944482457
-
Refractory generalised convulsive status epilepticus: A guide to treatment
-
DOI 10.2165/00023210-200519090-00003
-
Kalvainen R, Eriksson K, Parvainen I (2005) Refractory generalized status epilepticus: a guide to treatment. CNS Drug 19:759-768 (Pubitemid 41324063)
-
(2005)
CNS Drugs
, vol.19
, Issue.9
, pp. 759-768
-
-
Kalviainen, R.1
Eriksson, K.2
Parviainen, I.3
-
14
-
-
0036128487
-
Refractory status epilepticus: Frequency, risk factors, and impact on outcome
-
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59:205-210 (Pubitemid 34240935)
-
(2002)
Archives of Neurology
, vol.59
, Issue.2
, pp. 205-210
-
-
Mayer, S.A.1
Claassen, J.2
Lokin, J.3
Mendelsohn, F.4
Dennis, L.J.5
Fitzsimmons, B.-F.6
-
15
-
-
0000892632
-
Estimation of the absolute bioavailability oftopiramate in humans without intravenous data
-
Nayak RK, Gisclon LG, Curtin CA (1994) Estimation of the absolute bioavailability oftopiramate in humans without intravenous data. J Clin Pharmacol 34:1029
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 1029
-
-
Nayak, R.K.1
Gisclon, L.G.2
Curtin, C.A.3
-
16
-
-
0033533162
-
Topiramate reduces neuronal injury after experimental status epilepticus
-
DOI 10.1016/S0006-8993(99)01615-7, PII S0006899399016157
-
Niebauer M, Gruenthal M (1999) Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 837:263-269 (Pubitemid 29369240)
-
(1999)
Brain Research
, vol.837
, Issue.1-2
, pp. 263-269
-
-
Niebauer, M.1
Gruenthal, M.2
-
17
-
-
33744498652
-
Use of midazolam for refractory status epilepticus in pediatric patients
-
Pellock JM (1999) Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol 20:259-264
-
(1999)
J Child Neurol
, vol.20
, pp. 259-264
-
-
Pellock, J.M.1
-
18
-
-
33744493123
-
Topiramate loading for refractory status epilepticus in children
-
DOI 10.1111/j.1528-1167.2006.00564.x
-
Perry MS, Holt PJ, Sladky JT (2006) Topiramate loading for status epilepticus in children. Epilepsia 47:1070-1071 (Pubitemid 43801519)
-
(2006)
Epilepsia
, vol.47
, Issue.6
, pp. 1070-1071
-
-
Perry, M.S.1
Holt, P.J.2
Sladky, J.T.3
-
19
-
-
0029884747
-
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
-
Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-,800-and, 1000-mg daily dosages. Topiramate YE Study Group Neurology 46:1678-1683 (Pubitemid 26185792)
-
(1996)
Neurology
, vol.46
, Issue.6
, pp. 1678-1683
-
-
Privitera, M.1
Fincham, R.2
Penry, J.3
Reife, R.4
Kramer, L.5
Pledger, G.6
Karim, R.7
-
20
-
-
0029845689
-
Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy
-
Sachdeo RC, Sachdeo SK, Walker SA, Kramer LD, Nayak RK, Doose DR (1996) Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 37:774-780 (Pubitemid 26276948)
-
(1996)
Epilepsia
, vol.37
, Issue.8
, pp. 774-780
-
-
Sachdeo, R.C.1
Sachdeo, S.K.2
Walker, S.A.3
Kramer, L.D.4
Nayak, R.K.5
Doose, D.R.6
-
21
-
-
0035213619
-
Outcome of severe refractory status epilepticus in children
-
Sahin M, Menache CC, Holmes GL (2001) Outcome of severe refractory status epilepticus in children. Epilepsia 42:1411-1467
-
(2001)
Epilepsia
, vol.42
, pp. 1411-1467
-
-
Sahin, M.1
Menache, C.C.2
Holmes, G.L.3
-
22
-
-
0035058394
-
Topiramate and metabolic acidosis in pediatric epilepsy
-
DOI 10.1046/j.1528-1157.2001.04500.x
-
Takeoka M, Holmes GL, Thiele E, Bourgeois BF, Helmers SL, Duffy FH, Riviello JJ (2001) Topiramate and metabolic acidosis in pediatric epilepsy Epilepsia 42:387-392 (Pubitemid 32279651)
-
(2001)
Epilepsia
, vol.42
, Issue.3
, pp. 387-392
-
-
Takeoka, M.1
Holmes, G.L.2
Thiele, E.3
Bourgeois, B.F.4
Helmers, S.L.5
Duffy, F.H.6
Riviello, J.J.7
-
23
-
-
0037469169
-
The use of topiramate in refractory status epilepticus
-
Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ (2003) The use of topiramate in refractory status epilepticus. Neurology 60:332-334 (Pubitemid 36152034)
-
(2003)
Neurology
, vol.60
, Issue.2
, pp. 332-334
-
-
Towne, A.R.1
Garnett, L.K.2
Waterhouse, E.J.3
Morton, L.D.4
DeLorenzo, R.J.5
-
24
-
-
0242655295
-
Topiramate: As Monotherapy in Newly Diagnosed Epilepsy
-
DOI 10.2165/00023210-200317130-00007
-
Waugh J, Goa KL (2003) Topiramate: as monotheraphy in newly diagnosed epilepsy. CNS Drugs 17:985-992 (Pubitemid 37410073)
-
(2003)
CNS Drugs
, vol.17
, Issue.13
, pp. 985-992
-
-
Waugh, J.1
Goa, K.L.2
|